Latest stories
Featured
Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic®...
Press Release, Business Development
12 February 2024
- Hikma reiterates full year guidance following good start to the year Press Release, Corporate 24 April 2025 Hikma reiterates full year guidance following good start to the year
- Inspiring women of Hikma - Meet Nesrine Nouhi, General Manager of Hikma France Insight, Life at Hikma 17 April 2025 Inspiring women of Hikma - Meet Nesrine Nouhi, General Manager of Hikma France
- Hikma acquires Novugen’s FDA-approved ANDA for trametinib Press Release, Product 17 April 2025 Hikma acquires Novugen’s FDA-approved ANDA for trametinib
- Hikma signs exclusive licensing agreement with pharma& to bring innovative oncology treatment to MENA Press Release, Business Development 09 April 2025 Hikma signs exclusive licensing agreement with pharma& to bring innovative oncology treatment to MENA
Related content